1. Home
  2. PLUR
Logo Pluri Inc.

PLUR

Pluri Inc.

as 10-09-2025 1:09pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Founded: 2001 Country:
Israel
Israel
Employees: N/A City: HAIFA
Market Cap: 37.6M IPO Year: N/A
Target Price: $12.00 AVG Volume (30 days): 9.3K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.56 EPS Growth: N/A
52 Week Low/High: $3.33 - $7.13 Next Earning Date: 11-11-2025
Revenue: $1,336,000 Revenue Growth: 309.82%
Revenue Growth (this year): 246.11% Revenue Growth (next year): 169.62%

PLUR Daily Stock ML Predictions

Share on Social Networks: